Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis

Published:2013-12-16 Issue:5 Volume:16 Page:433-442
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Goring S.¹,Hawkins N.²,Wygant G.³,Roudaut M.⁴,Townsend R.⁵,Wood I.⁴,Barnett A. H.⁶

Affiliation:

1. Oxford Outcomes; Vancouver Canada

2. Oxford Outcomes; Oxford UK

3. Bristol-Myers Squibb; Princeton NJ USA

4. Bristol-Myers Squibb; Rueil-Malmaison France

5. AstraZeneca; Uccle Belgium

6. Diabetes Centre; Heart of England NHS Foundation Trust and University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12239/fullpdf

Reference58 articles.

1. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents;Hauber;Diabet Med,2009

4. Prevalence of overweight and obesity among adults with diagnosed diabetes - Unites States; 1988-1994 and 1999-2002;Centers for Disease Control and Prevention;Morb Mortal Wkly Rep,2004

5. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration;Diabetologia,2007

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

2. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience;World Journal of Diabetes;2024-03-15

3. Treatment Approaches and Challenges;Nanoscience Applications in Diabetes Treatment;2023-12-17

4. Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis;Cardiovascular Endocrinology & Metabolism;2023-05-08

5. Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study;Cureus;2023-04-27